+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticancer Agent"

Injectable Cytotoxic Drugs Market: Market Size, Trends, Opportunities and Forecast By Drug Class, Application, Distribution Channel, Region, By Country: 2020-2030 - Product Thumbnail Image

Injectable Cytotoxic Drugs Market: Market Size, Trends, Opportunities and Forecast By Drug Class, Application, Distribution Channel, Region, By Country: 2020-2030

  • Report
  • June 2024
  • 310 Pages
  • Global
From
Antibody Drug Conjugates Market Report by Component, Target, Application, End User, and Region 2024-2032 - Product Thumbnail Image

Antibody Drug Conjugates Market Report by Component, Target, Application, End User, and Region 2024-2032

  • Report
  • September 2024
  • 141 Pages
  • Global
From
Minimal Residual Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Minimal Residual Disease Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 138 Pages
  • Global
From
Soft Tissue Sarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 - Product Thumbnail Image

Soft Tissue Sarcoma Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034

  • Report
  • May 2024
  • 133 Pages
  • Global
From
Chemotherapy Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Thumbnail Image

Chemotherapy Drugs - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Drug Pipelines
  • July 2024
  • 100 Pages
  • Global
From
Antibody Drug Conjugate - Competitive Landscape, 2025 - Product Thumbnail Image

Antibody Drug Conjugate - Competitive Landscape, 2025

  • Report
  • March 2025
  • 450 Pages
  • Global
From
Peritoneal cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Peritoneal cancer - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 180 Pages
  • Global
From
Chemotherapy Induced Peripheral Neuropathy - Pipeline Insight, 2024 - Product Thumbnail Image

Chemotherapy Induced Peripheral Neuropathy - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 60 Pages
  • Global
From
Hepatic Tumor - Pipeline Insight, 2024 - Product Thumbnail Image

Hepatic Tumor - Pipeline Insight, 2024

  • Clinical Trials
  • June 2024
  • 240 Pages
  • Global
From
Chondrosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Chondrosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Testicular Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Testicular Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Biliary Tract Cancer (BTC) - Pipeline Insight, 2024 - Product Thumbnail Image

Biliary Tract Cancer (BTC) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 180 Pages
  • Global
From
Esophageal Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Esophageal Cancer - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Malignant Mesothelioma - Pipeline Insight, 2024 - Product Thumbnail Image

Malignant Mesothelioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 110 Pages
  • Global
From
Soft Tissue Sarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Soft Tissue Sarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
Desmoid Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Desmoid Tumors - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Castrate Resistant Prostrate Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Castrate Resistant Prostrate Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Neuroendocrine Tumors Market - Product Thumbnail Image

Neuroendocrine Tumors Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
mTOR Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Thumbnail Image

mTOR Inhibitors Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • February 2025
  • 185 Pages
  • Global
From
Oncology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F - Product Thumbnail Image

Oncology Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029F

  • Report
  • May 2024
  • 184 Pages
  • Global
From
Loading Indicator

The Anticancer Agent market is a segment of the Healthcare Services industry that focuses on the development and distribution of drugs and treatments for cancer. These agents are designed to target and destroy cancer cells while minimizing the damage to healthy cells. They can be administered orally, intravenously, or topically, depending on the type of cancer and the patient's individual needs. Anticancer agents are used in combination with other treatments such as radiation and chemotherapy to provide the best possible outcome for the patient. The Anticancer Agent market is highly competitive, with many companies vying for market share. Companies in this market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more